• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
HUANG Shiqin, SHI Min, HE Yingna, YUE Hanxun, YU Xian. Construction and in vitro evaluation of DC-targeted aptamer-modified Pseudomonas aeruginosa DNA vaccine delivery system[J]. Journal of China Pharmaceutical University, 2019, 50(6): 743-752. DOI: 10.11665/j.issn.1000-5048.20190616
Citation: HUANG Shiqin, SHI Min, HE Yingna, YUE Hanxun, YU Xian. Construction and in vitro evaluation of DC-targeted aptamer-modified Pseudomonas aeruginosa DNA vaccine delivery system[J]. Journal of China Pharmaceutical University, 2019, 50(6): 743-752. DOI: 10.11665/j.issn.1000-5048.20190616
shu

Construction and in vitro evaluation of DC-targeted aptamer-modified Pseudomonas aeruginosa DNA vaccine delivery system

More Information
    Graphical Abstract
    • Abstract
  • This study aimed to construct a DC-targeted aptamer-modified Pseudomonas aeruginosa(PA)DNA vaccine delivery system. The cationic liposome was prepared by ethanol injection method. The cationic liposome loading pVAX1-OprF-VP22(Lip-pOprF-VP22)was prepared by electrostatic adsorption method. The encapsulation efficiency of Lip-pOprF-VP22 with different mass ratios of DOTAP/pDNA on pVAX1-OprF-VP22, cytotoxicity and transfection rate to DC2. 4 in vitro were discussed. The particle size and zeta potential of Lip-pOprF-VP22 with best mass ratio were tested. Aptamer-modified cationic liposome loading pVAX1-OprF-VP22(Apt-Lip-pOprF-VP22)was prepared by post-insertion method. The expression of OprF protein after transfection of DC2. 4 and its effect on the maturation of bone marrow-derived dendritic cells(BMDCs)were detected. Data showed that as the mass ratio of DOTAP/pDNA increased, the encapsulation efficiency of Lip-pOprF-VP22 on pVAX1-OprF-VP22 was gradually increased. When the mass ratio was 5 ∶1, pVAX1-OprF-VP22 was encapsulated well. When Lip-pOprF-VP22 with different mass ratios was applied to DC2. 4 for 24 h or 48 h, the survival rates of DC2. 4 were all above 80%. When the mass ratio of DOTAP/pDNA increased from 2 ∶1 to 10 ∶1, the transfection rate increased first and then decreased. When the mass ratios of DOTAP/pDNA were 4 ∶1 and 5 ∶1, the transfection rates were relatively high. When the mass ratio of DOTAP/pDNA was 5 ∶1, the particle size of Lip-pOprF-VP22 was(171. 67±1. 27)nm, and the Zeta potential was(11. 30±0. 57)mV. Furthermore, Apt-Lip-pOprF-VP22 can express more OprF protein and significantly promote the maturation of BMDCs. In conclusion, Apt-Lip-pOprF-VP22 can target to DC and promote the maturation of DC.
    • FullText(HTML)
    • References (24)
  • [1]
    Tran CS,Rangel SM,Almblad H,et al.The Pseudomonas aeruginosa type III translocon is required for biofilm formation at the epithelial barrier[J].PLoS Pathog,2014,10(11):e1004479.DOI: 10.1371/journal.ppat.1004479.
    [2]
    Bassetti M,Vena A,Croxatto A,et al.How to manage Pseudomonas aeruginosa infections[J].Drugs Context,2018,7:212527.
    [3]
    Hassan R,El-Naggar W,Abd El-Aziz AM,et al.Immunization with outer membrane proteins(OprF and OprI)and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa[J].J Microbiol Immunol Infect, 2018,51(3):312-320.
    [4]
    Yu X,Wang Y,Xia YF,et al.A DNA vaccine encoding VP22 of herpes Simplex virus type I(HSV-1)and OprF confers enhanced protection from Pseudomonas aeruginosa in mice[J].Vaccine,2016,34(37):4399-4405.
    [5]
    Ullstrom CA,Siehnel R,Woodruff W,et al.Conservation of the gene for outer membrane protein OprF in the family Pseudomonadaceae:sequence of the Pseudomonas syringae oprF gene[J].J Bacteriol, 1991,173(2):768-775.
    [6]
    Rello J,Krenn CG,Locker G,et al.A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients[J].Crit Care,2017,21(1):22.
    [7]
    Lim S,Koo JH,Choi JM.Use of cell-penetrating peptides in dendritic cell-based vaccination[J].Immune Netw,2016,16(1):33-43.
    [8]
    Elliott G,O'Hare P.Intercellular trafficking and protein delivery by a herpesvirus structural protein[J].Cell,1997,88(2):223-233.
    [9]
    Zhen S, Takahashi Y, Narita S, et al. Targeted delivery of CRISPR/Cas9 to prostate cancer by modified gRNA using a flexible aptamer-cationic liposome[J].Oncotarget,2017,8(6):9375-9387.
    [10]
    Chen K,Liu B,Yu B,et al.Advances in the development of aptamer drug conjugates for targeted drug delivery[J].Wiley Interdiscip Rev Nanomed Nanobiotechnol,2017,9(3).doi: 10.1002/wnan.1438.
    [11]
    Ganji A,Varasteh A,Sankian M.Aptamers:new arrows to target dendritic cells[J].J Drug Target,2016,24(1):1-12.
    [12]
    Lahoud MH,Ahmet F,Zhang JG,et al.DEC-205 is a cell surface receptor for CpG oligonucleotides[J].Proc Natl Acad Sci U S A,2012,109(40):16270-16275.
    [13]
    Jiang W,Swiggard WJ,Heufler C,et al.The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing[J].Nature,1995,375(6527):151-155.
    [14]
    Wengerter BC,Katakowski JA,Rosenberg JM,et al.Aptamer-targeted antigen delivery[J].Mol Ther,2014,22(7):1375-1387.
    [15]
    Allen TM,Sapra P,Moase E.Use of the post-insertion method for the formation of ligand-coupled liposomes[J].Cell Mol Biol Lett,2002,7(3):889-894.
    [16]
    Inaba K,Inaba M,Romani N,et al.Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor[J].J Exp Med,1992, 176(6):1693-1702.
    [17]
    Schwendener RA. Liposomes as vaccine delivery systems: a review of the recent advances[J].Ther Adv Vaccines,2014,2(6):159-182.
    [18]
    Heurtault B,Saulnier P,Pech B,et al.Physico-chemical stability of colloidal lipid particles[J].Biomaterials,2003,24(23):4283-4300.
    [19]
    Xu Y,Shi L,Deng YH.Effect of polyethylene glycol-lipid derivatives on the stability of grafted liposomes[J].Acta Pharm Sin(药学学报),2011,46(10):1178-1186.
    [20]
    Fischer D,Bieber T,Li Y,et al.A novel non-viral vector for DNA delivery based on low molecular weight,branched polyethylenimine:effect of molecular weight on transfection efficiency and cytotoxicity[J].Pharm Res,1999,16(8):1273-1279.
    [21]
    Villate-Beitia I, Truong NF, Gallego I, et al. Hyaluronic acid hydrogel scaffolds loaded with cationic niosomes for efficient non-viral gene delivery[J].RSC Adv,2018,8(56):31934-31942.
    [22]
    Yuan DF,Sun MJ,Wang Y,et al.Preparation and in vitro characterization of octreotide-targeting doxorubicin liposome[J].J China Pharm Univ(中国药科大学学报),2011,42(13):223-229.
    [23]
    Kala S,Mak AS,Liu XX,et al.Combination of dendrimer-nanovector-mediated small interfering RNA delivery to target Akt with the clinical anticancer drug paclitaxel for effective and potent anticancer activity in treating ovarian cancer[J].J Med Chem,2014,57(6):2634-2642.
    [24]
    Swanson JA.Shaping cups into phagosomes and macropinosomes[J].Nat Rev Mol Cell Biol,2008,9(8):639-649.
    • Related Articles

  • Related Articles

    [1]LIU Li, PEI Siran, WU Huali, ZHAO Qingshun, PENG Jixian, SHANG Jing. Drug screening model of treating pigmentation disorders in tyrp1a transgenic zebrafish[J]. Journal of China Pharmaceutical University, 2016, 47(6): 740-743. DOI: 10.11665/j.issn.1000-5048.20160618
    [2]SHAO Xin, YI Qianying, YANG Chunlei. Discovery of novel EphB4 inhibitors based on pharmacophore modeling and virtual screening techniques[J]. Journal of China Pharmaceutical University, 2016, 47(1): 38-47. DOI: 10.11665/j.issn.1000-5048.20160105
    [3]HE Hua, ZHANG Xue, WANG Yuhao, LIU Xiaoquan. Advances in pharmacokinetic and pharmacodynamic modeling of monoclonal antibody[J]. Journal of China Pharmaceutical University, 2015, 46(3): 279-288. DOI: 10.11665/j.issn.1000-5048.20150304
    [4]TANG Chunlei, HUANG Wenlong, QIAN Hai. Construction and application of 3D-pharmacophore model of glucokinase agonists[J]. Journal of China Pharmaceutical University, 2015, 46(2): 181-187. DOI: 10.11665/j.issn.1000-5048.20150208
    [5]HE Xiaobei, LIU Xiaodong. Physiologically based pharmacokinetic model of mechanism-based inhibition of theophylline/caffeine by enoxacin/ciprofloxacin[J]. Journal of China Pharmaceutical University, 2013, 44(1): 77-84. DOI: 10.11665/j.issn.1000-5048.20130113
    [6]REN Xin-yi, CHEN Yuan-cheng, WANG Yan, XIAO Yuan-yuan, LIU Xiao-quan. Pharmacokinetic-pharmacodynamic(PK-PD) modeling of salvianolic acid A on the plasma homocysteine in rats[J]. Journal of China Pharmaceutical University, 2012, 43(3): 260-265.
    [7]Linear Model for Prediction of Drug Shelf Life[J]. Journal of China Pharmaceutical University, 1999, (2): 69-72.
    [8]Yang Jinghua, Song Xiangzheng. The Markovian Model C in Pharmacokinetics[J]. Journal of China Pharmaceutical University, 1997, (1): 59-62.
    [9]Animal ECG Automatic Sample and Analysis-process by Computer[J]. Journal of China Pharmaceutical University, 1995, (5): 304-307.
    [10]Computer Program for the Effect Parameters of Combined Pharmacokinetic and Pharmacodynamic Model[J]. Journal of China Pharmaceutical University, 1990, (3): 142-146.

Catalog

    Get Citation
    PDF
    XML
    Article views (401) PDF downloads (849) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：311835

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return